APA-referens (7:e uppl.)

Chaiyakunapruk, N., Tan, X., Liang, Y., Guevarra, M., Xie, L., & Cheng, A. Y. Y. (2025). Real-world effectiveness of adding newer generation GLP-1RA to SGLT2i in type 2 diabetes. Cardiovascular Diabetology, 24(1), 1. https://doi.org/10.1186/s12933-025-02737-1

Chicago-referens (17:e uppl.)

Chaiyakunapruk, Nathorn, Xi Tan, Yuanjie Liang, Mico Guevarra, Lin Xie, och Alice Y. Y. Cheng. "Real-world Effectiveness of Adding Newer Generation GLP-1RA to SGLT2i in Type 2 Diabetes." Cardiovascular Diabetology 24, no. 1 (2025): 1. https://doi.org/10.1186/s12933-025-02737-1.

MLA-referens (9:e uppl.)

Chaiyakunapruk, Nathorn, et al. "Real-world Effectiveness of Adding Newer Generation GLP-1RA to SGLT2i in Type 2 Diabetes." Cardiovascular Diabetology, vol. 24, no. 1, 2025, p. 1, https://doi.org/10.1186/s12933-025-02737-1.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.